Episodes
Friday Apr 01, 2016
Investing in Healthcare and Biotechnology
Friday Apr 01, 2016
Friday Apr 01, 2016
TEKLA Capital Management LLC's Daniel R. Omstead, Ph.D., President and Chief Executive Officer, discusses:
• The appeal of the biotechnology sector
• Opportunities in pre-public venture companies
• The Affordable Care Act and other factors influencing healthcare investing
• Why TEKLA is using a closed-end fund structure
Version: 20241125